yuxiang dong
University of Nebraska Medical Center
Omaha, United States
Associate Editor
Experimental Pharmacology and Drug Discovery
University of Nebraska Medical Center
Omaha, United States
Associate Editor
Experimental Pharmacology and Drug Discovery
University of Turin
Turin, Italy
Associate Editor
Ethnopharmacology
Uppsala University
Uppsala, Sweden
Associate Editor
Drug Metabolism and Transport
Centers for Disease Control and Prevention (CDC)
Atlanta, United States
Associate Editor
ELSI in Science and Genetics
School of Pharmacy, Liaoning University of Traditional Chinese Medicine
Da Lian, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Namur
Namur, Belgium
Associate Editor
Translational Pharmacology
University of Pittsburgh
Pittsburgh, United States
Associate Editor
Neuropharmacology
Icahn School of Medicine at Mount Sinai
New York, United States
Associate Editor
Neuropharmacology
KU Leuven
Leuven, Belgium
Associate Editor
Obstetric and Pediatric Pharmacology
Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences
Bratislava, Slovakia
Associate Editor
Neuropharmacology
School of Law, New York University
New York City, United States
Associate Editor
ELSI in Science and Genetics
Stony Brook University
Stony Brook, United States
Associate Editor
Neuropharmacology
West China School of Medicine, West China Hospital, Sichuan University
Chengdu, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
Griffith Health, Griffith University
Southport, Australia
Associate Editor
Translational Pharmacology
UMR7370 Laboratoire de Physio Médecine Moléculaire (LP2M)
Nice, France
Associate Editor
Pharmacology of Ion Channels and Channelopathies
Research Centre for Food and Nutrition, Council for Agricultural Research and Economics
Rome, Italy
Associate Editor
Ethnopharmacology